Industry

Piramal Pharma to acquire remaining 26% stake in Yapan Bio

The Hindu - Industry·19 Nov 2026

With the acquisition, Piramal will fully embed Yapan’s advanced large molecule capabilities into its integrated service offering

More news in Industry